Assessing the Implementation of American College of Surgeons Quality Indicators for Pancreatic Cancer Across an Integrated Health System.


Journal

Journal of oncology practice
ISSN: 1935-469X
Titre abrégé: J Oncol Pract
Pays: United States
ID NLM: 101261852

Informations de publication

Date de publication:
08 2019
Historique:
pubmed: 2 7 2019
medline: 8 8 2020
entrez: 2 7 2019
Statut: ppublish

Résumé

The American College of Surgeons (ACS) recently published quality assurance (QA) indicators for pancreatic cancer care. Implementing quality indicators in a newly formed health system may lead to better patient selection and standardized cancer care. Select ACS and internal quality indicators were implemented system wide in 2014. We compared compliance with these measures before and after their implementation at the main hospital and two new affiliate institutions. A total of 506 patients with pancreatic cancer were included. At the main hospital in the pre-QA period, 11 (12.6%) of 87 patients were discussed at our institutional multidisciplinary tumor board meeting; this number rose to 89 (49.7%) of 179 patients ( The implementation of ACS quality indicators at our main hospital was feasible and effective for several measures, without delaying treatment. Instituting these indicators at lower-volume affiliates was more challenging.

Identifiants

pubmed: 31260384
doi: 10.1200/JOP.18.00587
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e739-e745

Auteurs

Daniel Solomon (D)

1Icahn School of Medicine at Mount Sinai, New York, NY.

Natasha DeNicola (N)

1Icahn School of Medicine at Mount Sinai, New York, NY.

Yael Feferman (Y)

1Icahn School of Medicine at Mount Sinai, New York, NY.

Daniela Feingold (D)

1Icahn School of Medicine at Mount Sinai, New York, NY.

Samantha N Aycart (SN)

1Icahn School of Medicine at Mount Sinai, New York, NY.

Deepa R Magge (DR)

1Icahn School of Medicine at Mount Sinai, New York, NY.

Benjamin J Golas (BJ)

1Icahn School of Medicine at Mount Sinai, New York, NY.

Fadi Attiyeh (F)

1Icahn School of Medicine at Mount Sinai, New York, NY.

Daniel M Labow (DM)

1Icahn School of Medicine at Mount Sinai, New York, NY.

Umut Sarpel (U)

1Icahn School of Medicine at Mount Sinai, New York, NY.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH